The Burr Broadcast: OSHA Clarifies Work-Relatedness of Employee Injuries While Traveling
The Presumption of Innocence Podcast: Episode 29 - A Global Perspective on the Economic Responses to COVID-19
Employment Law Now VI-119 - What Did You Miss This Summer?
#WorkforceWednesday: Updated CDC Guidance, Monkeypox Outbreak, and EEO-1 Pay Data - Employment Law This Week®
Taking the Pulse: A Health Care and Life Sciences Video Podcast - Ep. 111 with Will Britt, Chief Counsel for Public Health, SC DHEC
What Employers Need to Know About NY HERO Act Updates
Where Do We Stand on COVID-19? A Conversation with Andy Slavitt
Hot Spots in Employment Law 2022
Employment Law Now VI-110 - End of the OSHA ETS? Supreme Court Re-Issues A Stay
CMS Vaccine Rule for Health Care Workers - Employment Law This Week®
Employment Law Now V-106 - BREAKING OSHA ETS NEWS: Extending the Stay and Choosing a Lottery Winner
#WorkforceWednesday: Biden’s Employer Vaccine Mandate, NY HERO Act Safety Plans, Cannabis Cases - Employment Law This Week®
#WorkforceWednesday: Biden Touts Employer-Mandated Vaccines, Booster Shot Questions, and EEO-1 Deadline Delayed
Employment Law Now V-100 - The Latest on Vaccine Policies and Bellwether States
#WorkforceWednesday: OSHA Updates COVID-19 Guidance, NLRB GC’s Priorities, Biometrics at Work - Employment Law This Week®
#WorkforceWednesday: Vaccine Mandates, Mandate Bans, Wage and Hour Nomination Stalls - Employment Law This Week®
Where are We Now? The Evolution of Workplace COVID-19 Vaccination Guidance
Law Firm ILN-telligence Podcast | Episode 34: Gil Rosen | Joseph Shem Tov & Co. | Israel
#WorkforceWednesday: COVID-19 Restrictions Tighten, NYC Fair Chance Act, Biden's Budget - Employment Law This Week®
Employer Vaccine Mandates
New Trump Administration tariffs on Canada, Mexico, and China. On February 1, 2025, President Donald Trump signed three Executive Orders instituting sweeping new tariffs on all goods imported from Canada, Mexico, and China,...more
On August 19, 2020, the Trump administration made a major announcement that marks the latest development in the ever-evolving saga of the Food and Drug Administration’s (FDA) oversight of laboratory-developed tests (LDTs)....more